Robert P. Perrillo

13.3k total citations · 6 hit papers
119 papers, 10.1k citations indexed

About

Robert P. Perrillo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Robert P. Perrillo has authored 119 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Epidemiology, 99 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Robert P. Perrillo's work include Hepatitis C virus research (92 papers), Hepatitis B Virus Studies (87 papers) and Liver Disease Diagnosis and Treatment (58 papers). Robert P. Perrillo is often cited by papers focused on Hepatitis C virus research (92 papers), Hepatitis B Virus Studies (87 papers) and Liver Disease Diagnosis and Treatment (58 papers). Robert P. Perrillo collaborates with scholars based in United States, Canada and United Kingdom. Robert P. Perrillo's co-authors include Jules L. Dienstag, Eugene R. Schiff, Karen L. Lindsay, Andrew L. Mason, Robert G. Gish, Janice K. Albrecht, Henry C. Bodenheimer, Ira M. Jacobson, John A. Payne and William D. Carey and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Robert P. Perrillo

115 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

1989 1.4k citations Gary L. Davis, Eugene R. Schiff et al. New England Journal of Medicine profile →
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

1995 680 citations Jules L. Dienstag, Robert P. Perrillo et al. New England Journal of Medicine profile →
A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

1990 664 citations Robert P. Perrillo, E. Schiff et al. New England Journal of Medicine profile →
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

1992 570 citations Robert P. Perrillo et al. New England Journal of Medicine profile →
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection

1999 523 citations Andrew L. Mason, Robert P. Perrillo et al. Hepatology profile →
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

2014 373 citations Robert P. Perrillo, Robert G. Gish et al. Gastroenterology profile →

Peers

Countries citing papers authored by Robert P. Perrillo

Since Specialization

Citations

This map shows the geographic impact of Robert P. Perrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Perrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Perrillo more than expected).

Fields of papers citing papers by Robert P. Perrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Perrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Perrillo. The network helps show where Robert P. Perrillo may publish in the future.

Co-authorship network of co-authors of Robert P. Perrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Perrillo. A scholar is included among the top collaborators of Robert P. Perrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Perrillo. Robert P. Perrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B 2022 ·The American Journal of Gastroenterology ·Norah A. Terrault, Anna S. Lok, Abdus S. Wahed, Marc G. Ghany, Robert P. Perrillo, Michael Fried, David Wong, Mandana Khalili, Daryl Lau, Richard K. Sterling, Adrian M. Di Bisceglie, Mauricio Lisker‐Melman, Stewart Cooper, Ray Chung, Keyur Patel, Lewis R. Roberts, Steven H. Belle, Harry L.A. Janssen	11
2	Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection 2022 ·Clinical Gastroenterology and Hepatology ·Jordan J. Feld, Wendy C. King, Marc G. Ghany, Kyong‐Mi Chang, Norah A. Terrault, Robert P. Perrillo, Mandana Khalili, Amanda S. Hinerman, Harry L.A. Janssen, Anna S. Lok	3
3	Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy 2016 ·Clinical Infectious Diseases ·Stevan A. Gonzalez, Robert P. Perrillo	46
4	American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy breakdown → 2014 ·Gastroenterology ·Robert P. Perrillo, Robert G. Gish, Yngve Falck–Ytter	373
5	Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable 2012 ·Annals of Internal Medicine ·Anna S. Lok, John W. Ward, Robert P. Perrillo, Brian J. McMahon, T. Jake Liang	62
6	Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B 2008 ·Journal of Hepatology ·Joseph J.�Y. Sung, (unknown), Stefan Zeuzem, (unknown), E. Jenny Heathcote, Robert P. Perrillo, Carol Brosgart, Mary Woessner, (unknown), DF Gray, Stephen D. Gardner	117
7	Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders 2003 ·Journal of Hepatology ·Eugene R. Schiff, Jules L. Dienstag, Selim Karayalçın, Ian S. Grimm, Robert P. Perrillo, Petr Husa, Robert A. de Man, Zachary Goodman, Lynn D. Condreay, (unknown), Mary Woessner, (unknown), Nathaniel Brown	95
8	Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease 2001 ·Gastroenterology ·Robert P. Perrillo	328
9	Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: Is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? 2001 ·Hepatology ·Satheesh Nair, Robert P. Perrillo	66
10	The A to Z of new hepatotropic agents: Human hepatitis viruses and monkey business 1996 ·Liver Transplantation and Surgery ·Andrew L. Mason, Robert P. Perrillo	4
11	A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection breakdown → 1995 ·New England Journal of Medicine ·Jules L. Dienstag, Robert P. Perrillo, Eugene R. Schiff, (unknown), (unknown), Marc Rubin	680
12	The management of chronic hepatitis B 1994 ·The American Journal of Medicine ·Robert P. Perrillo	16
13	Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis 1993 ·Gastroenterology ·Andrew L. Mason, Mark R. Wick, Heather M. White, Kent G. Benner, Randall G. Lee, Frederic Regenstein, Caroline A. Riely, Vincent G. Bain, Carolyn Campbell, Robert P. Perrillo	50
14	Interferon for hepatitis B: US experience. 1993 ·Gut ·Robert P. Perrillo	2
15	Hepatitis B: transmission and natural history. 1993 ·Gut ·Robert P. Perrillo	17
16	Antiviral therapy of chronic hepatitis B: past, present, and future 1993 ·Journal of Hepatology ·Robert P. Perrillo	22
17	Interferon in the management of chronic hepatitis B 1993 ·Digestive Diseases and Sciences ·Robert P. Perrillo	72
18	HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B 1991 ·Hepatology ·(unknown), Stanford T. Roodman, Carolyn Campbell, (unknown), Robert P. Perrillo	9
19	Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial 1990 ·Journal of Hepatology ·Gary L. Davis, (unknown), Eugene R. Schiff, Karen L. Lindsay, Henry C. Bodenheimer, Robert P. Perrillo, William D. Carey, Ira M. Jacobson, John A. Payne, Jules L. Dienstag, David H. Van Thiel, Carlo H. Tamburro, Jay H. Lefkowitch, Janice K. Albrecht, Carlton Meschievitz, Terryl J. Ortego, Alexandra L. Gibas	16
20	A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B breakdown → 1990 ·New England Journal of Medicine ·Robert P. Perrillo, E. Schiff, Gerald L. Davis, Henry C. Bodenheimer, Karen L. Lindsay, John A. Payne, Jules L. Dienstag, C. O’Brien, Carlo H. Tamburro, Ira M. Jacobson, Richard E. Sampliner, (unknown), Jay H. Lefkowitch, Mary C. Kuhns, Carlton Meschievitz, Bharati Sanghvi, Janice K. Albrecht, Alexandra L. Gibas	664

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact